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Abstract
Background: The literature shows the inverse association between physical activity level (PAL) and chronic diseases
that have a significant burden over health care costs. However, in upper-middle income countries and in elderly
population this information are scarce.
Objective: To describe the annual drug expenditures for the hypertensive and diabetic elderly population in Brazil
and to analyze the association with PAL and engagement in walking.
Methods: This cross sectional study is part of SABE Survey and comprised 806 hypertensive and/or diabetic elderly
(≥60 years old). The annual expenditures of medicine use was estimated for all medications for hypertension and/
or diabetes they were taking. The PAL was considered insufficient when moderate physical activity was <150 min/
week or vigorous physical activity was < 75 min/week. Engagement in walking was considered by at least 1 day a
week. All expenditures were presented through the descriptive values (in American Dollars US$) according PAL and
engagement in walking. The association analysis between annual expenditures, PAL and engagement in walking
were performed by multiple logistic regression models adjusted for gender, age and body mass index.
Results: The average annual cost was higher in diabetic and insufficient physically activity elderly. The 1-year
estimated.cost was US$ 73386,09 and 295% higher in insufficiently physically active. Older people who reported
not walking had a higher risk to higher annual expenditures of medicine use (OR = 1.57, 95% CI 1.03–2.40).
Conclusions: The annual expenditures of medicine use for controlling hypertension and diabetes of Brazilian
elderly were higher and inversely associated with physical activity level and engagement in walking.
Keywords: Expenditures, Physical Activity, Elderly, Medicine use, Hypertension, Diabetes
Background
The prevalence of hypertension (HTS) among elderly la-
tinos (Mexico, Paraguay and Venezuela) is 67.3% in men
and 61.1% in women, increasing to 70% among those se-
niors aged 70 or higher [1]. For diabetes mellitus (DM),
according to data provided by the Base Population
Health Census taken in municipalities in São Paulo state,
the disease was self-reported by 14.9% of men and 15.8%
of women over 60 years old [2].
There is increasing literature, identifying that chronic
diseases have a significant burden over health care costs
[3, 4]. In the pharmacological intervention for control of
HTS and DM, the simultaneous use of more than one
type of drug is quite common, with direct consequences
to the costs billed to the health system. Compared to
normotensive and non-diabetic patients, drug costs are
higher for those affected by the disease [5, 6] Among the
non-pharmacological methods of control, physical activ-
ity (PA) is widely recommended for hypertensive [7] and
* Correspondence: denisebueno@usp.br
1Department of Nutrition, Faculty of Public Health, University of Sao Paulo,
Avenida Doutor Arnaldo, 715, Cerqueira César, São Paulo, SP CEP: 01246-904,
Brazil
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Bueno et al. BMC Geriatrics  (2017) 17:70 
DOI 10.1186/s12877-017-0437-0
diabetic persons [8] due to its effect in lowering at-rest
blood pressure [9] and glycemia [10, 11]. Williams [12]
showed that the use of drugs was lower as a result of en-
gaging in walking exercise. Other studies showed that
intervention by means of PA results in lower overall
health care costs [13] and, specifically, lower drug use
[14, 15]. Analysis of expenditures in Canadá estimates
that in 2009 the direct costs due to hypertension (US$
588 million) and DM (US$ 470 million) directly attribut-
able to physical inactivity (<150 min per week) are
higher than those among active people [16]. Tsuji et al.
[17] demonstrated lower healthcare costs in a population
of physically active seniors.
Investigations of this nature are extremely important
given the phenomenon of the transition of the popula-
tional age structure, and the resulting increase in the
numbers of older people, who also have the highest
health care costs in comparison to young adults [6, 18].
A Brazilian study estimated that the costs of controlling
DM will reach US$ 8.7 billion in 2050, corresponding to
the increase of US$ 3.7 billion when compared to 2010.
For HTS, the analyses indicate that, in 2050, the cost
will reach US$ 657 million [19]. In the US, the cost of
drugs for treatment of DM represents 28% of the avail-
able healthcare resources and for treatment of hyperten-
sion the main cost was the use of drugs [20].
However, information of this nature in Brazil is still
scarce, especially as regards large populational studies
focused on the elderly. The aim of this study was to de-
scribe the annual drug cost for the elderly population of
the city of São Paulo and to analyze the association of
these costs with PA level and walking.
Methods
The SABE Survey and sample
The SABE Survey (Health, Welfare and Aging Survey) is
a home-focused epidemiological study and the aim was
to investigate health characteristics relating to the elderly
population in developing countries. In Brazil, the SABE
Survey was developed in the urban area of the capital of
São Paulo state and it was approved by the Ethics
Committee of the Public Health School of University of
São Paulo, control number 475,455. The participants
were invited to read and approve a consentient letter
before to start all the assessments and interviews, where
was explained about sharing their data (age, self-
reported data, physical activity level and others) to scien-
tific work, and agreeing about their names or personal
data wouldn’t be used in the publications. The datasets
generated and/or analyzed during the current study
which were used under license for the current study are
not publicly available due to the policy of SABE Survey,
and so are not publicly available. Data are however avail-
able from the authors upon reasonable request.
For this cross-sectional study, the SABE data used was
collected in 2010, and comprised a total of 1,211 elderly
people. However, in order to meet the objective of inves-
tigating the association of drug costs among hyperten-
sive and/or diabetic seniors, only those who reported
these diseases in the interview were included in this
sample. Those seniors were also excluded that did not
include complete information in the questionnaire, as
was necessary for analysis (body mass or/and height).
Having satisfied the requirements described, 806 elderly
individuals participated in the study.
Outcome variable - annual expenditures of medicine use
The elderly individuals were told to describe all medica-
tions they were taking, so that the analysis could include
both prescription and self-medicating/over-the-counter
drugs. Herbal medicines were not considered, given that
they are not included among those provided by Unified
Health System in Brazil. Those drugs that were bought
from formularies were also not considered, given the im-
possibility of obtaining standard pricing. The exact na-
ture of drug costs included only those drugs that were
identified as being indicated for the treatment of HTS
and DM and became apparent after three stages:
1. Estimated daily amount consumed: this was
determined by the Defined Daily Dosage (DDD),
which is the average daily dosage of the drug in its
use for its main indication [21];
2. Price identification: this data was taken from a
survey of the Healthcare Price Database (http://
www.bps.saude.gov.br), and considered the amount
of the dosage unit (1 tablet, 1 pill or 1 capsule).
3. Estimation of monthly and annual expenditures: the
daily cost estimated from the DDD was multiplied
by 30 (days) for each product, and then multiplied
by 12 (months), to reflect the annual cost. Then, a
currency value update was carried out based on the
most recent data available from the Consumer Price
Index as provided by the Brazilian Institute of
Geography and Statistics (IBGE-IPCA).
Annual expenditures of medicine use was divided into
quartiles, with the last quartile of cost (US$ ≥ 75th) con-
sidered as highest expenditures group. The first three
quartiles (US$ < 75th) represent the lowest annual ex-
penditures group.
Explanatory variable
Physical activity level and walking
The participants’ physical activity was self-reported
using the short version of the International Physical
Activity Questionnaire (IPAQ). The elderly were classi-
fied according to their physical activity level (PAL) in
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accordance with current recommendations [22]: i. Ac-
tive: ≥ 150 min/ week of moderate PA, or ≥ 75 min/
week of vigorous PA; ii. Insufficiently active: <150 min/
week of moderate PA or <75 min/ week of vigorous PA.
Walking was reported according to the weekly fre-
quency of engagement. The elderly were divided into
two groups: i) Yes: Seniors who walked at least 1 day a
week; ii) No: older adults who did no walking. Moreover,
to see the difference on costs according to the frequency
of walking in a week they were divided into three
groups: i) ≥ 4 days a week; ii) 1 to 3 days per week; iii)
does not walk (0 days per week).
Statistical analysis
This is a population-based study derived from complex
samples. So, the statistical analyses and tests used were
those indicated for use with survey-type studies (svy).
For the complete visualization of costs, in Dollars
(US$), they are presented through the mean values and
their respective 95% confidence intervals (CI 95%), me-
dian values and values of percentile 25 (25th) and per-
centile 75 (75th).
To association analysis the expenditures of medicine
use (outcome variable) was divided into quartiles, with
the last quartile of cost (US$ ≥ 75th) considered a risk
category (highest cost). The first three quartiles (US$ <
75th) are representing the reference category (lowest
cost). The multiple logistic regression models (Rao &
Scott test) were adjusted for sex, age and body mass
index, and comorbidities.
To examine associations of costs with PAL (reference:
active, risk: insufficiently active) and walking (reference:
walking ≥ 4 days, risk: walking < 4 days) by gender, three
multiple logistic regression models were performed
separately, using these variables as explanatory variables,
including analysis for men and women. The overall re-
gression model was performed adjusted by gender, Body
Mass Index (BMI), age, marital status, socioeconomic
status and education level. The other analyses (separated
according to gender) were adjusted for age and BMI.
The significance level was established in 5% for all ana-
lysis and statistical analyses were provided by Stata 10.1.
Results
Of the 806 elderly individuals in the sample, 60.9% were
female (n = 526), 95.9% (n = 767) reported being affected
by high blood pressure and 62.5% (n = 295) for diabetes,
with no differences in the prevalence of HTS and DM
by gender (p > 0.05). The average age of the sample was
70.7 (95%-CI = 70.2 to 71.3) years of age and does not
differed between the hypertensive and diabetic.
According to the self-reported weekly time of physical
activity, 72% (n = 575) of the elderly were classified as in-
sufficiently active and of these, 54.7% were women.
39.4% of the sample self-reported the engagement in
walking in ≥ 4 days/week (48.7% men and 33.4% women,
p = 0.002) and 32% self-reported no walking (no differ-
ence between sex). The chi-square test demonstrated no
difference in the PAL with the prevalence of hypertension
and diabetes (p = 0.14 and p = 0.55, respectively). As can
be seen from the results shown in the graph in Fig. 1, the
majority of the elderly, both hypertensive (71.4%) and dia-
betic (73.3%) were classified as insufficiently active.
The total number of drugs for hypertension and dia-
betes was 2,141, being 1,770 antihypertensive and 371
anti-diabetic, with an average of 2.6 (95%-CI 2.5–2.7)
drugs per elderly, with no difference between sexes (p >
0.05). In seniors who only had HTS, the average was 2.0
(95%-CI 1.9–2.2) medicines without a difference accord-
ing PAL (p > 0.05). The average use of antidiabetic drugs
in patients that reported only DM was 2.2 (95%-CI 1.7–
2.7), with no difference between PAL and walking exer-
cise (p > 0.05). In patients that reported both diseases,
the average of antihypertensive and antidiabetic drugs
was 3.8 (95%-CI 3.6–4.1). When considering all the
drugs taken by the 806 seniors, 72.2% were presented by
elderly people with an insufficient PAL.
The average annual cost for drugs per individual was
US$ 85.40 (IC95% 68.79–102.00), similar by sex and
higher in the groups of more elderly people with insuffi-
cient PAL. The 1-year estimated cost was US$ 73.386,09
for the 806 older adults in this sample (Table 1), and
295% higher in the group classified as being insuffi-
ciently physically active. Analyzing costs by the median,
the costs were higher for the same groups when com-
pared to the average; albeit with less of a difference be-
tween the values.
Costs by medication type
The medicines acting on the renin-angiotensin system
were higher (24%), but its total cost in 1 year was
lower than that observed in the use of antidiabetic,
Fig. 1 Prevalence of inactive and active individuals according to the
self-reported chronic disease
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antihypertensive, as well as lipid-lowering, agents,
which amounted to the highest annual cost (Table 2).
The multiple association analysis that was performed
to all sample demonstrated that not walking was directly
associated with risk to higher annual spending with
medicine use, adjusted for confounders. Male group had
higher chances of high drug costs when they were classi-
fied as insufficiently active (OR 3.19, 95% CI 95% 1:10 to
9:30). Women who did not report walking were more
likely to have higher annual medicine costs (OR 1.83,
95% CI 95% 1:08 to 3:09) (Table 3).
When considering all the sample, regardless of gender
and disease, the results presented in Fig. 2 show that
there was no association of the overall PAL with highest
annual cost of medication (OR = 1.21, 95% CI 95% 0.82–
1.80), adjusted for gender, age and BMI. However, as it
related to walking, and stratified by the frequency of
their engagement in walking, older people who reported
not walking during the week had a higher risk of being
included in the group reporting higher medication costs
(OR = 1.57, 95% CI 95% 1.03–2.40), compared to those
seniors who reported walking on four or more days a
week (Fig. 2).
Discussion
The aim of the present study was to describe the annual
medication expenditures for hypertensive and diabetic
older adults and to analyze their associations with PAL
and weekly engagement in walking. The results showed
inverse associations for engagement in walking, adjusted
for gender, age and BMI.
As indicated in the literature [5], hypertensive had
higher use and cost of medications when compared to
normotensive. Therefore, studies suggest that PA, espe-
cially aerobic training, helps in keeping blood pressure
at normal levels, resulting in a reduced need for medica-
tion use and costs. Even though the PA was of moderate
intensity, such as walking [22–24], it exerts hypotensive
effects and controlling the disease. This study was
grounded in this information and therefore was based
on the assumption that costs would be lower among
physically active hypertensive older adults. Indeed, our
results are confirming the literature because indicates
that there is a positive and direct relationship between
the annual cost per person and the control rate of
hypertension, where-in Brazil-the monthly cost for the
pharmacological control of hypertension is lower when
blood pressure was < 140/90 mmHg [25].
Likewise, the cost for non-diabetic elderly is lower
than the cost for diabetic [26] and physical inactivity is
present in most individuals affected by DM [27]. On the
other hand, there are also indications that a physically
active lifestyle mitigates this situation and contributes to
the regulation of blood glucose [28, 29] and a decreased
risk of complications related to DM due to the improved
metabolic profile of these individuals [27]. Thus, in
addition to the cost of the disease, diabetic individuals
with a lower PAL present higher costs for medications
for other conditions [30].
Table 1 Description of annual expenditures for medicine use
according gender, PAL and walking. (São Paulo, 2015 [n = 806])
Annual expenditures of medicine use-US$
Variable Mean (CI 95%)-Median
[25th- 75th]
Sum - ∑
All sample 85.40 (68.79–102.00) –
20.89 [15.05; 53.05]
73.386.09
Gender
Men 84.90 (54.55–115.25) –
17.71 [3.22; 49.03]
25.553.35
Woman 85.72 (66.65–14.79) –
21.69 [4.82; 54.64]
47.832.74
PAL
Active 60.57 (43.83–77.32) –
16.67 [4.82; 43.42]
14.816.44
Insufficiently active 95.07 (72.99–117.16) –
22.49 [4.82; 54.68]
58.569.66
Walking
Yes 77.55 (59.57–95.54) –
17.71 [3.22; 44.97]
42.918.59
No 102.03 (67.05–137.02) –
25.71 [6.41; 62.64]
30.467.51
Walking
No Walking 102.03 (52.16–107.92) –
25.71 [6.41; 62.64]
30.467.51
1–3 days 74.13 (55.32–92.94) –
20.89 [4.82; 57.87]
16.534.61
≥ 4 days 80.04 (67.19–137.02) –
17.67 [3.22; 41.79]
26.383.96
Note: PAL Physical activity level, CI 95%– confidence interval 95%
Table 2 Prevalence of medicine use (%) and annual
expenditures sum (∑ − US$) according to medicine type.
(São Paulo, 2015 [n = 806])
Type of medication Prevalence of
medicine use (%)
∑ Annual Cost
US$
Renin Angiotensin System
controller
24.3 4782.19
Diuretics 18.4 3155.22
Anti-diabetics 17.8 13244.32
Lipid-lowering agents 11.5 20221.64
Beta Blockers 10.7 4141.92
Calcium channel blockers 10.2 1622.26
Cardiovasculars 4.1 12710.62
Anti-hypertensive 2.0 10667.27
Vasodilators 1.0 745.99
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In direction of these findings, in a 2-year study of Ital-
ian diabetic sufferers with an average age of 62, those
who managed to increase energy expenditure through
PA showed an equivalent reduction in drug use costs
[11]. But, these results about PAL were not concordant
with our results. However, our findings are in agreement
with Codogno et al. [31], who did not observe lower
drug costs for these different PAL among diabetic eld-
erly, however, there was an inverse association of costs
with the overall PA (OR 2.12, 95% CI 1.18–3.78) when
considering the domains of work and sports activities to-
gether. On the other hand, the costs for controlling both
diseases were lower with engagement in walking as
shown by Williams [12] who showed a lower rate of use
of antidiabetic and antihypertensive medications in phys-
ically active individuals. Thus, further studies with the
elderly population are needed to more clearly elucidate
the associations of physical activity and walking to redu-
cing drug costs.
On these disagreements in literature, a plausible ex-
planation would be the self-reported method of analysis
of physical activity. It is noteworthy that the PAL esti-
mated by the IPAQ in this study was largely carried out
in the free time of those who reported it. In addition,
studies demonstrate that the PAL estimated by the IPAQ
may be overestimated [32] to the extent that seniors
classified as physically active may not actually be, thus
diminishing the strength of the association of physical
inactivity to costs for the entire sample. On the other
hand, these results are similar to Tsuji et al. [16], who
observed inverse associations between cost and engage-
ment in walking. In this regard, IPAQ validation studies
show that the correlation of responses relating to walk-
ing with objective measurements (accelerometer) is
greater than that relating to the responses for moderate
and vigorous PA, especially in older women [33]. Thus,
different areas of PA can be linked in different ways to
healthcare costs, and the sum of daily energy expend-
iture may be the real determinant in cost reductions,
such that further studies are needed to investigate these
associations in Brazilian older adults, the results of
which would indicate the best alternatives for interven-
tion projects.
As regards the expenditures in diabetics, one possible
explanation is the need for constant use of insulin, re-
gardless of the PAL due to dysfunction of beta cells,
which irreversibly reduces their natural production.
Kaizu et al. [10] observed that although leisurely PA
entails positive effects on the metabolic profile of dia-
betic patients, the proportion of individuals using oral
Table 3 Association between PAL and walking with higher annual expenditures of medicine use (≥75th), to overall sample and
according to gender
Annual expenditures of medicine use (≥75th)
Overall (n = 806) Men (n = 281) Women (n = 525)
Groups/Variable OR CI 95% p OR CI 95% p OR CI 95% p
Model 1 PAL
Active 1.00 – 1.00 – 1.00 –
Insuf. Active 1.27 0.86–1.86 0.23 3.19 1.10–9.30 0.03 0.94 0.41–2.20 0.90
Model 2 Walking
Yes 1.00 – 1.00 – 1.00 –
No 1.39 0.96–2.00 0.07 1.04 0.53–2.02 0.91 1.51 0.97–2.35 0.07
Model 3 Walking
≥ 4 days 1.00 – – 1.00 – 1.00 –
1–3 days 1.56 1.00–2.43 0.05 1.78 0.78–4.07 0.16 1.42 0.83–2.43 0.20
No Walking 1.70 1.11–2.58 0.01 1.27 0.62–2.60 0.51 1.83 1.08–3.09 0.02
Note: PAL Physical activity level, OR Odds ratio, CI Confidence interval, Logistic regression models adjusted for gender, BMI age, marital status, socioeconomic
status, andeducational level
Fig. 2 Odd s ratio to highest expenditures according to
engagement in walking. Logistic regression models
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hypoglycemic agents was not lower in individuals who
were classified as active.
As it relates to public health interventions, the results
presented are of extreme value and, when added to the re-
sults of other studies [34, 35], demonstrated that non-
pharmacological intervention procedures for blood glucose
and blood pressure control, especially through engagement
in walking, have conclusive results and are cost-effective,
and point to possible cost savings through primary preven-
tion strategies. Thus, it can be inferred that these interven-
tion strategies can result in the positive effect of reducing
the costs associated with the control of the disease, since
the cost savings at this primary level would mean lower
costs at subsequent levels of public health services [36].
The PA at internationally recommended levels [22, 37]
was low for both hypertensive and diabetic subjects. It is
worth noting that studies are consistent in showing a
greater prevalence of hypertension in insufficiently active
individuals, especially among older adults [38]. Addition-
ally, there is evidence that the risk of hypertension
decreases concomitantly as level of cardiorespiratory fit-
ness is increased [40]. Thus, our results are showing that
the primary prevention strategy for reducing risk variables
through aerobic training as walking seems to be feasible
and economically interesting. Specifically in the case of
Brazilian costs, a study published in 2010 showed that the
cost of HTS reached US$ 398.9 million, consuming 1.43%
of the resources of the nationalized healthcare program
[41], and of this amount, 52.3% was spent with medica-
tion. Thus, since walking can be an aid in controlling the
disease and reducing medicine use, this study points to a
necessary and plausible intervention strategy to be
employed among the older adults, aimed at saving finan-
cial resources for healthcare program.
In addition, the benefits of PA or walking may be more
significant if we consider the lower costs classified as in-
direct and/or intangible, both by improving quality of
life and well-being, as well as the inverse association of
PAL to the risk of mortality among the hypertensive [42]
and diabetic [43]. Other Brazilian population studies
should be performed with the purpose of presenting the
indirect costs associated with physical inactivity in order
to strengthen the basis for the elaboration of public pol-
icies aimed at saving financial resources.
This study stands out for having been conducted with
a representative sample of older adults living in São
Paulo, however, it has some limitations. Readers need to
do generalizations carefully. There are not a rural sample
in this analysis, and Brazilians older people are classified
according to the age ≥ 60 years-old. Although the esti-
mate of the PAL through the IPAQ is feasible in epi-
demiological studies [33] and commonly performed in
population surveys [39, 44, 45], it can be overestimated
[46], and merits care in the interpretation of the results
presented. Another limitation is the self-reported diag-
nosis of HTS and DM via interview format, which in-
creases the chance of healthy seniors composing the
sample and/or hypertensive or diabetic seniors being ex-
cluded from the analysis. It is noteworthy that this study
did not carry out comparisons between elderly patients
affected and not affected by the disease, nor were HTS
and DM considered the conclusion of the analysis. Thus,
memory bias does not seem to be a problem for the in-
terpretation of the results of this study.
Conclusions
In conclusion, engagement in walking was inversely associ-
ated with the annual cost due to medication use, independ-
ent from body mass index, gender and age, among
hypertensive and/or diabetic older adults living in São
Paulo city, Brazil. The epidemiological evidence of this
study conducted with a representative sample of older
hypertensive and diabetic individuals indicates the prospect
of physical activity interventions. Thus, PA plays an import-
ant task saving public health resources and controlling
chronic diseases among the elderly adults. Moreover, the
cross-sectional design prejudices the conclusions regarding
the relationship between medicine use expenditures and
PAL or walking.
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